In short: India has cut TB deaths faster than the world average, according to the WHO Global Tuberculosis Report 2026, and has found lakhs of hidden cases through mass screening. Yet TB remains India’s leading infectious killer. The next phase must cut new infections, tackle drug resistance and address undernutrition and other social causes of the disease.
Syllabus: GS Paper 2: Issues relating to development and management of the social sector relating to health; Government policies and interventions; Important international institutions · Source: PIB, Ministry of Health and Family Welfare; WHO Global Tuberculosis Report 2026 · 13 November 2026
Why is it in the news?
The WHO Global Tuberculosis Report 2026, released on 12 November 2026, records a 38% fall in India’s estimated TB mortality since 2015, against a global decline of 35%. The Ministry of Health and Family Welfare said this is India’s highest-ever reduction. The report used data from the Sample Registration System, community-based verbal autopsies and the Ni-kshay portal to estimate deaths.
The policy framework
| Measure | What it does |
|---|---|
| National TB Elimination Programme (NTEP) | Central programme for diagnosis, free treatment and monitoring of TB; earlier called the Revised National TB Control Programme |
| TB Mukt Bharat Abhiyaan (from 7 December 2024) | Intensified screening in high-risk areas; a second 100-day campaign from 24 March 2026 covers 1.58 lakh high-risk villages and wards |
| Ni-kshay Poshan Yojana | Direct benefit transfer to TB patients for nutrition during treatment |
| Ni-kshay Mitra | Individuals, firms and institutions adopt patients and give nutritional and psychosocial support |
| Ni-kshay portal | Digital system for case notification, patient tracking and treatment monitoring |
| JOSH Teams | Block and ward teams led by designated senior officers with NCC cadets and MY Bharat volunteers for awareness and outreach |
Health dimension
- Early detection: Over 25 crore people were screened between 7 December 2024 and 8 November 2026, with more than 11 crore chest X-rays and over 3 crore NAAT tests.
- Hidden cases: Of the 48.64 lakh new cases detected, 14.97 lakh had no symptoms, and such people would otherwise have kept spreading the infection.
- Treatment: The 94% success rate for drug-susceptible TB shows that patients who are diagnosed are largely completing treatment.
- Comorbidities: Screening is now combined with checks for diabetes and undernutrition, which raise both the risk of TB and the risk of death.
Social and economic dimension
- Poverty and nutrition: TB is closely linked to undernutrition, crowded housing and poor ventilation, so it hits the poor hardest.
- Income loss: Long illness and treatment cause lost wages and high out-of-pocket costs, which can push families into debt.
- Stigma: Fear of social exclusion delays testing, especially among women and migrant workers.
- Community action: 67,933 Panchayats were declared TB-free in 2025, which shows the value of local ownership.
Governance dimension
- Funding: About 96% of the TB programme’s needs are met from domestic resources, which reduces dependence on external donors.
- Technology: AI tools are used to map hotspots, predict patients at risk of poor outcomes and reach people through the Khushi chatbot.
- Data: An ICMR-NIRT national TB prevalence survey was conducted in 2025 and is under technical discussion with WHO before India’s country profile is updated.
- Global goals: SDG target 3.3 and the WHO End TB Strategy aim to end the TB epidemic by 2030.
Critical Analysis
The fall in deaths is a real gain, and the scale of screening has no parallel in India’s past efforts. However, India had set itself the goal of ending TB by 2025, five years ahead of the SDG deadline, and that goal has not been met. Lower mortality shows better diagnosis and treatment, but elimination needs a steep fall in new infections, and the incidence picture will be clear only after WHO reviews the 2025 prevalence survey. Drug-resistant TB needs longer and costlier treatment. A large share of patients first visit private providers, where notification and follow-up are uneven. Finally, the detection of nearly 15 lakh symptom-free cases points to a large hidden reservoir, which means the actual burden may be higher than routine data suggest.
Way Forward
- Expand TB preventive treatment for household contacts and other high-risk groups to cut transmission.
- Make molecular testing available at every primary health facility, and test all presumptive cases for drug resistance.
- Raise nutrition support and link TB patients to food security schemes and social protection.
- Bring private providers fully into notification, free drugs and follow-up through incentives and digital tools.
- Fight stigma through community champions, Panchayats and schools.
- Publish incidence estimates from the prevalence survey, so that progress is judged on infections as well as deaths.
India’s TB response has moved from waiting for patients to finding them, and deaths are falling. Ending TB will need the same energy to stop new infections, which depends as much on nutrition, housing and income as on medicines.
Key Facts for Prelims
- WHO Global TB Report 2026: India’s TB mortality fell 38% since 2015 (global: 35%).
- India’s TB mortality rate: 28 per lakh (2015) to 18 per lakh (2025).
- Treatment success rate for drug-susceptible TB: 94%.
- TB Mukt Bharat Abhiyaan began on 7 December 2024 in 347 high-priority districts.
- WHO End TB Strategy: 90% fewer deaths and 80% lower incidence by 2030, compared with 2015.
- SDG target 3.3 covers ending the epidemics of AIDS, tuberculosis and malaria by 2030.
Practice Questions
Q1. With reference to the WHO End TB Strategy, consider the following statements:
1. It aims to reduce TB incidence by 80% by 2030, compared with 2015.
2. It sets 2025 as the target year for ending TB worldwide.
Which of the statements given above is/are correct?
- 1 only
- 2 only
- Both 1 and 2
- Neither 1 nor 2
Show answer
Answer: (a) Statement 1 is correct. Statement 2 is wrong: the global targets are for 2030 and 2035; 2025 was India’s own national goal for ending TB.
Q2. NAAT, widely used under the TB Mukt Bharat Abhiyaan, is:
- A vaccine against tuberculosis
- A molecular test that detects the genetic material of the TB bacterium
- A chest imaging technique
- A drug regimen for resistant TB
Show answer
Answer: (b) A nucleic acid amplification test detects the genetic material of Mycobacterium tuberculosis; some NAAT platforms also detect resistance to rifampicin.
Q. India has reduced TB mortality faster than the global average, yet the goal of TB elimination remains distant. Examine the reasons and suggest measures to accelerate progress. (15 marks, 250 words)
Approach: Introduce with the WHO Global TB Report 2026 figures. In the body, cover active case finding, nutrition support, domestic funding and digital tools, then the gaps: incidence, drug resistance, private sector, stigma and social determinants. Conclude with prevention and social protection.
FAQs
What does the WHO Global TB Report 2026 say about India?
The report records a 38% fall in India’s estimated TB mortality between 2015 and 2025, from 28 to 18 per lakh population, and a 94% treatment success rate for drug-susceptible TB.
What is the TB Mukt Bharat Abhiyaan?
It is an intensified campaign launched on 7 December 2024 in 347 high-priority districts and later extended nationwide, using AI-enabled chest X-rays and NAAT tests to find TB cases early, including those without symptoms.
What are the End TB Strategy targets?
The WHO End TB Strategy aims to reduce TB deaths by 90% and TB incidence by 80% by 2030, and by 95% and 90% respectively by 2035, compared with 2015.
Why is nutrition support important in TB control?
Undernutrition weakens immunity and is a leading risk factor for TB in India, so support through the Ni-kshay Poshan Yojana and Ni-kshay Mitra improves recovery and treatment outcomes.
हिंदी सारांश
WHO वैश्विक टीबी रिपोर्ट 2026 के अनुसार 2015 से 2025 के बीच भारत में टीबी मृत्यु दर 38% घटकर प्रति लाख 28 से 18 रह गई, जबकि वैश्विक गिरावट 35% रही। दवा-संवेदनशील टीबी में उपचार सफलता दर 94% है। टीबी मुक्त भारत अभियान में 25 करोड़ से अधिक लोगों की जाँच हुई और 48.64 लाख नए मामले मिले, जिनमें 14.97 लाख बिना लक्षण वाले थे। चुनौतियों में नए संक्रमण घटाना, दवा-प्रतिरोधी टीबी, कुपोषण, निजी क्षेत्र की रिपोर्टिंग और सामाजिक कलंक शामिल हैं। पोषण, शीघ्र जाँच और सामुदायिक भागीदारी इसके समाधान के प्रमुख आधार हैं।
Sources: PIB: India makes major strides towards TB elimination (12 Nov 2026); WHO Global Tuberculosis Programme.
Related reading on GSMitra: PIB News Today for UPSC: 13 November 2026, Daily Editorial Analysis 13 November 2026, UPSC Prelims Current Affairs 13 November 2026.
Revise this topic with a custom test in the GSMitra MCQ Test Builder, or get your Mains answers on it evaluated 1:1 through GSMitra mentorship. Prefer to talk first? Book a free consultation on WhatsApp.